(A-B) Groups of 5–9 C57Bl/6J mice were challenged by intranasal instillation with 2,000 (circles) or 500 (squares) colony forming units (CFU) in 10μL (black), 20μL (grey), or 30μL (white) of Yersinia pestis KIM6+pCD1Ap, a wild type strain. (A) Survival was monitored for 14 days; n = 16–21 per group, collected in 3 independent trials. Data were combined and analyzed by Mantel-Cox log rank test, survival curves with the same letter are not significantly different. (B) Mice were euthanized at 6 hours post infection (HPI) and CFU in the lungs or at 48 HPI and CFU in the lungs and spleen determined. Dashed line indicates the lower limit of detection, with numbers below that line representing undetected animals for that group; light grey line ind...
<p>Mice were infected intranasally with 5×10<sup>7</sup> CFU WT GBS and cytokine levels in cell-free...
<p><b>A</b>: Relative lung weights were calculated as a percentage of total body mass (mean +− SE). ...
A. A strategy designed for mice challenge with P. aeruginosa via an intranasal administration. As de...
Groups of C57Bl/6J mice were challenged in parallel with the same inoculation dose of an attenuated ...
Groups of 5–6 C57Bl/6J mice were challenged by intranasal infection with 10μL containing 2,000 CFU w...
<p>Mice were challenged with CO92 (113,000 CFU) or Δ<i>tatA</i> mutant (76,000 CFU). At set time poi...
<p>BALB/c mice were challenged by intranasal infection with 1×10<sup>4</sup> CFU of WT <i>Y. pestis<...
<p>A and B) Skull sections (4×) of a mouse challenged with the Δ<i>tatA</i> mutant (2,800 CFU). The ...
Yersinia pestis is the causative agent of pneumonic plague, a disease involving uncontrolled bacteri...
<p>From a single challenge study, mice were exposed intranasally with Schu S4 (131 CFU), CipR mutant...
<p>Seven-day-old mice were intranasally challenged with 5×10<sup>5</sup> CFU TIGR4 strain (10 µl/mou...
<p>(A) Total cell numbers of innate immune cell populations in the lungs of mice inoculated with 10<...
(A) Animal mortality (n = 30 in three experiments for Ptx3-/- and C57BL/6 mice) (p B) bacterial load...
<p><b>(A)</b> Mice were immunized with PBS, SL3261 (vector), or SL3261/p1C3 (vaccine) via the intran...
<p>Mice were challenged with D39, D39Δ<i>spd1837</i>, D39Spd1837<sub>C8S,</sub> D39Δ<i>spd1838</i>, ...
<p>Mice were infected intranasally with 5×10<sup>7</sup> CFU WT GBS and cytokine levels in cell-free...
<p><b>A</b>: Relative lung weights were calculated as a percentage of total body mass (mean +− SE). ...
A. A strategy designed for mice challenge with P. aeruginosa via an intranasal administration. As de...
Groups of C57Bl/6J mice were challenged in parallel with the same inoculation dose of an attenuated ...
Groups of 5–6 C57Bl/6J mice were challenged by intranasal infection with 10μL containing 2,000 CFU w...
<p>Mice were challenged with CO92 (113,000 CFU) or Δ<i>tatA</i> mutant (76,000 CFU). At set time poi...
<p>BALB/c mice were challenged by intranasal infection with 1×10<sup>4</sup> CFU of WT <i>Y. pestis<...
<p>A and B) Skull sections (4×) of a mouse challenged with the Δ<i>tatA</i> mutant (2,800 CFU). The ...
Yersinia pestis is the causative agent of pneumonic plague, a disease involving uncontrolled bacteri...
<p>From a single challenge study, mice were exposed intranasally with Schu S4 (131 CFU), CipR mutant...
<p>Seven-day-old mice were intranasally challenged with 5×10<sup>5</sup> CFU TIGR4 strain (10 µl/mou...
<p>(A) Total cell numbers of innate immune cell populations in the lungs of mice inoculated with 10<...
(A) Animal mortality (n = 30 in three experiments for Ptx3-/- and C57BL/6 mice) (p B) bacterial load...
<p><b>(A)</b> Mice were immunized with PBS, SL3261 (vector), or SL3261/p1C3 (vaccine) via the intran...
<p>Mice were challenged with D39, D39Δ<i>spd1837</i>, D39Spd1837<sub>C8S,</sub> D39Δ<i>spd1838</i>, ...
<p>Mice were infected intranasally with 5×10<sup>7</sup> CFU WT GBS and cytokine levels in cell-free...
<p><b>A</b>: Relative lung weights were calculated as a percentage of total body mass (mean +− SE). ...
A. A strategy designed for mice challenge with P. aeruginosa via an intranasal administration. As de...